Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer

Overview of attention for article published in Cochrane database of systematic reviews, May 2020

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 55,582 followers.

RT @Cochrane_GNOCG: New Cochrane protocol looking at the benefits and harms of anti-angiogenesis agents for the treatment of metastatic and…

New Cochrane protocol looking at the benefits and harms of anti-angiogenesis agents for the treatment of metastatic and recurrent cervical cancer https://t.co/5fcjMD5KrZ @brachyexpert @RasiahBharathan @CochraneLibrary @CochraneUK

RT @Cochrane_GNOCG: New Cochrane protocol - Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurr…

New Cochrane protocol - Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer https://t.co/5fcjMDnlQz @CochraneLibrary @CochraneUK #cervicalcancer